Rani Therapeutics Holdings Inc [NASDAQ: RANI] jumped around 0.06 points on Monday, while shares priced at $0.7 at the close of the session, up 8.45%.
Rani Therapeutics Holdings Inc stock is now -78.77% down from its year-to-date (YTD) trading value. RANI Stock saw the intraday high of $0.8658 and lowest of $0.56 per share. The company’s 52-week high price is 4.19, which means current price is +51.20% above from all time high which was touched on 02/14/25.
Compared to the average trading volume of 476.12K shares, RANI reached a trading volume of 61328663 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Rani Therapeutics Holdings Inc [RANI]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RANI shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RANI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Rani Therapeutics Holdings Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on August 02, 2024. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on June 14, 2024, representing the official price target for Rani Therapeutics Holdings Inc stock. Previously, the target price had yet another raise to $10, while Rodman & Renshaw analysts kept a Buy rating on RANI stock.
How has RANI stock performed recently?
Rani Therapeutics Holdings Inc [RANI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 30.23. With this latest performance, RANI shares gained by 21.95% in over the last four-week period, additionally sinking by -48.65% over the last 6 months – not to mention a drop of -49.02% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RANI stock in for the last two-week period is set at 65.70, with the RSI for the last a single of trading hit 0.0789, and the three-weeks RSI is set at 0.0704 for Rani Therapeutics Holdings Inc [RANI]. The present Moving Average for the last 50 days of trading for this stock 0.6278, while it was recorded at 0.6530 for the last single week of trading, and 1.4495 for the last 200 days.
Rani Therapeutics Holdings Inc [RANI]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Rani Therapeutics Holdings Inc [RANI] shares currently have an operating margin of -3965.00% and a Gross Margin at 14.08%. Rani Therapeutics Holdings Inc’s Net Margin is presently recorded at -2483.25%.
Return on Equity for this stock declined to -76.76%, with Return on Assets sitting at -76.76%.
Earnings analysis for Rani Therapeutics Holdings Inc [RANI]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RANI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Rani Therapeutics Holdings Inc go to 24.06%.
Insider trade positions for Rani Therapeutics Holdings Inc [RANI]
There are presently around $10.15%, or 14.06% of RANI stock, in the hands of institutional investors. The top three institutional holders of RANI stocks are: VANGUARD GROUP INC with ownership of 0.71 million shares, which is approximately 2.7265%. NAN FUNG GROUP HOLDINGS LTD, holding 0.49 million shares of the stock with an approximate value of $$1.88 million in RANI stocks shares; and NAN FUNG GROUP HOLDINGS LTD, currently with $$1.7 million in RANI stock with ownership which is approximately 1.7227%.
